| Test Article | Matrix | Species | Anticoagulant | Assay Type | LLOQ-ULOQ |
|---|---|---|---|---|---|
| 4-Hydroxycyclophosphamide | Plasma | Human | Heparin | LC-MS/MS | 5-500 |
| 4-Ketocyclophosphamide | Plasma | Human | Heparin | LC-MS/MS | 0.1-10 |
| Abiraterone | Plasma | Human | EDTA/Heparin | LC-MS/MS | 0.5-420 |
| Bendamustine and M3 and M4 Metabolites | Plasma | Human | Heparin | LC-MS/MS | 1-1000 |
| Bortezomib | Plasma | Human | Heparin | LC-MS/MS | 1-250 |
| Capecitabine and Metabolites (Prodrug for 5-Fluorouracil) | Plasma | Human | Heparin | LC-MS/MS | 75-10000 |
| Cyclophosphamide | Plasma | Human | Heparin | LC-MS/MS | 250-25000 |
| Cyclophosphamide | Plasma | Human | Heparin | LC-MS/MS | 1-100 |
| Daunorubicin | Plasma | Human | EDTA | LC-MS/MS | 1-1000 |
| Dechloroethylcyclophosphamide | Plasma | Human | Heparin | LC-MS/MS | 0.1-10 |
| Docetaxel | Plasma Ultrafiltrate | Human | Heparin | LC-MS/MS | 2-100 |
| Docetaxel | Plasma | Human | EDTA/Heparin | LC-MS/MS | 1-1000 |
| Docetaxel | Plasma Ultrafiltrate | Human | Heparin | LC-MS/MS | 2-100 |
| Docetaxel | Plasma | Mouse | Heparin | LC-MS/MS | 50-5000 |
| Docetaxel | Plasma | Dog | Heparin | LC-MS/MS | 10-2500 |
| Docetaxel | Plasma | Human | Heparin | LC-MS/MS | 10-2500 |
| Docetaxel | Plasma | Human | Heparin | LC-MS/MS | 10 |
| Doxorubicin | Plasma | Human | EDTA | LC-MS/MS | 1-1000 |
| Gemcitabine | Plasma | Human | EDTA | LC-MS/MS | 1-1000 |
| Gemcitabine and 2’,2’-Difluoro-2’-Deoxyuridine (dFdU) Metabolite | Plasma (THU-treated) | Human | Heparin | LC-MS/MS | 50-50000 |
| Lenalidomide | Plasma | Human | EDTA | LC-MS/MS | 1-1000 |
| Methotrexate and 7-Hydroxymethotrexate Metabolite | Plasma | Human | Heparin | LC-MS/MS | 1-1000 |
| Methotrexate and 7-Hydroxymethotrexate Metabolite | Urine | Human | None | LC-MS/MS | 20-10000 |
| Octenidine | Plasma | Human | EDTA | LC-MS/MS | 1-10 |
| Paclitaxel | Seminal Fluid | Human | None | LC-MS/MS | 0.1-100 |
| Paclitaxel | Urine | Human | None | LC-MS/MS | 0.1-100 |
| Paclitaxel | Plasma | Dog | Heparin | LC-MS/MS | 0.1-100 |
| Paclitaxel | Urethral and Prostate Tissues | Dog | None | LC-MS/MS | 0.3-300 |
| Paclitaxel | Urethral and Prostate Tissues | Dog | None | LC-MS/MS | 0.3-400 |
| Paclitaxel | Plasma | Human | EDTA | LC-MS/MS | 5-5000 |
| Paclitaxel | Plasma | Rat | Heparin | LC-MS/MS | 0.1-100 |
| Paclitaxel | Arterial Tissue | Porcine | None | LC-MS/MS | 0.5-500 |
| Paclitaxel | Plasma | Human | Heparin | LC-MS/MS | 20-5000 |
| Paclitaxel | Seminal Fluid | Human | None | LC-MS/MS | 0.1-100 |
| Paclitaxel | Plasma Ultrafiltrate | Dog | EDTA | LC-MS/MS | 0.3-1000 |
| Paclitaxel | Serum | Porcine | None | LC-MS/MS | 0.03-30 |
| Paclitaxel | Whole Blood | Dog | Heparin | LC-MS/MS | 1-1000 |
| Paclitaxel | Whole Blood | Porcine | None | LC-MS/MS | 0.03-30 |
| Paclitaxel | Urine | Porcine | None | LC-MS/MS | 0.03-30 |
| Paclitaxel | Plasma | Porcine | EDTA/Heparin | LC-MS/MS | 0.03-30 |
| Paclitaxel | Whole Blood | Human | None | LC-MS/MS | 1-1000 |
| Paclitaxel | Plasma or Plasma Ultrafiltrate | Human | EDTA/Heparin | LC-MS/MS | 0.1-1000 |
| Paclitaxel | Serum | Mouse | None | LC-MS/MS | 0.3-300 |
| Paclitaxel | Serum | Dog | None | LC-MS/MS | 0.03-30 |
| Paclitaxel | Plasma | Dog | Heparin | LC-MS/MS | 0.1-100 |
| Paclitaxel | Serum | Porcine | None | LC-MS/MS | 0.03-100 |
| Paclitaxel | Tissues | Porcine | None | LC-MS/MS | 0.3-500 |
| Paclitaxel | Plasma | Rabbit | EDTA/Heparin | LC-MS/MS | 0.03-30 |
| Paclitaxel | Serum | Rabbit | None | LC-MS/MS | 0.03-30 |
| Paclitaxel and 6α-Hydroxy Paclitaxel Metabolite | Plasma | Human | EDTA | LC-MS/MS | 1-1000 |
| Paclitaxel, 3-OH-Paclitaxel, & 6-OH-Paclitaxel | Dog & Rat Plasma | Heparin | LC-MS/MS | 0.100 | |
| Rapamycin | Whole Blood (Lysed) | Cat | EDTA | LC-MS/MS | 0.1-100 |
| Rapamycin | Whole Blood (Lysed) | Monkey | EDTA | LC-MS/MS | 0.1-100 |
| Rapamycin | Whole Blood (Lysed) | Monkey | EDTA | LC-MS/MS | 1000-40000 |
| Sunitinib and N-desethyl Sunitinib | Plasma | v | EDTA | LC-MS/MS | 1-100 |
| Tamoxifen | Plasma | Human | Heparin | LC-MS/MS | 0.5-500 |
| Temozolomide | Plasma | Rat | Heparin | LC-MS/MS | 10-2000 |